Results 231 to 240 of about 420,339 (355)

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru, Akansha Chandrasekar, Kyla Blasingame, Jonathan Rosen, Jesse M. Levine, Karla Salazar, Madhuri Chilakapati, Rod Foroozan, Victoria Hardwick, Jonathan M. Yarimi, Nikita Shukla, Timothy E. Lotze, Kristen S. Fisher, Alexander J. Sandweiss   +13 more
wiley   +1 more source

Population pharmacokinetic analysis of remimazolam after continuous infusion for sedation in critically ill patients. [PDF]

Front Pharmacol
Chen J, Wang X, Chen D, Liu X, Peng K, Tang R, Hu L, Wang Y, Bai Y, Chang L, Chen C.   +10 more
europepmc   +1 more source

Continuous Intravenous Glucose Infusion Tests

Folia Endocrinologica Japonica, 1973
Hideo YOSHIDA, Osamu AOJI, Hiroshi HATTORI, Keiich FUKUNAGA, Junzo YODA, Yasuo WAKABAYASHI, Toshihide YOSHIDA, Koji NAKANO   +7 more
openaire   +3 more sources

Validation of a Genetic Risk Score Combined With Clinical Variables for Predicting Pulmonary Fibrosis in Early Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). This study aimed to externally validate a genetic risk score (GRS) and a combined risk score (CRS) for predicting the risk of RA‐associated PF in an independent cohort of patients with early RA.
Mikael Brink, Austin Wheeler, Bryant R. England, Solbritt Rantapää‐Dahlqvist   +3 more
wiley   +1 more source

Continuous infusion OPAT via elastomeric pumps: effectiveness, safety, and cost-saving potential in a real-world Italian cohort. [PDF]

Infection
Babich S, Di Bella S, De Rivo R, Durojaiye OC, Lovecchio A, Misin A, Straciug M, Gobbo Y, Dellaluce A, Palmolungo M, Fabricci M, Di Girolamo FG, Roni C, Monticelli J.   +13 more
europepmc   +1 more source

Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome [PDF]

David H. McDermott, Shamik Majumdar, Daniel Velez, Elena Cho, Z. Li, Ji‐Liang Gao, Megan C. Grieco, Monica G. Lawrence, Susana L. Silva, Leslie Castelo‐Soccio, Dean Follmann, Philip M. Murphy   +11 more
openalex   +1 more source

Performance Characteristics of Anti–Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti–collagen II (Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick, Marcela A. Ferrada, Alice Fike, Kaitlin A. Quinn, Benjamin A. Turturice, Casey Stein, Peter C Grayson   +6 more
wiley   +1 more source

Response to Cojutti and Pea, "Is it Time to Move From Intermittent to Continuous Infusion Administration of Vancomycin?" [PDF]

Open Forum Infect Dis
Shiau J, Roy S, Sabourenkov P, Scheetz MH.   +3 more
europepmc   +1 more source

Combining Three Peripheral Blood Biomarkers to Stratify Rheumatoid Arthritis–Associated Interstitial Lung Disease Risk

Arthritis Care &Research, EarlyView.
Objective The purpose was to evaluate a biomarker score consisting of MUC5B rs35705950 promoter variant, plasma matrix metalloproteinase‐7 (MMP‐7), and serum anti–malondialdehyde‐acetaldehyde (anti‐MAA) antibody for rheumatoid arthritis (RA)–associated interstitial lung disease (ILD) risk stratification.
Kelsey Coziahr, Austin M. Wheeler, Brent A. Luedders, Michael Duryee, Halie Frideres, Katherine D. Wysham, Grant W. Cannon, Gary Kunkel, Dana P. Ascherman, Paul A. Monach, Gail S. Kerr, Andreas M. Reimold, Scott M. Matson, Joshua F. Baker, Geoffrey M. Thiele, Ted R. Mikuls, Bryant R. England   +16 more
wiley   +1 more source

Author Response: Continuous Infusion of Linezolid: Explaining the Discrepant Survival Outcomes between Two Studies. [PDF]

Indian J Crit Care Med
Albadry AM.
europepmc   +1 more source